Bioidentical hormones are defined as human-made hormones that are very similar to the human body's hormones. These are then used to treat men and women whose own hormones are low or out of balance. Bioidentical hormones come in various forms, including pills, patches, creams, gels, and injections. Bioidentical hormones are different from those used in traditional hormone replacement therapy (HRT) like they're identical chemically to those produced naturally and made from plant estrogens.
MARKET DYNAMICS
The Bioidentical hormones market is driving due to increasing geriatric population, growing screening for hormonal deficiency, rising awareness among consumers about bioidentical hormones and rising income level of women. Moreover, increasing risk of heart attack and breast cancer may hinder the market growth.
MARKET SCOPE
The "Bioidentical Hormones Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of bioidentical hormones market with detailed market segmentation by type, product type, and end user. The bioidentical hormones market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in bioidentical hormones market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The bioidentical hormones market is segmented on the basis of type, product type, and end user. Based on type, the market is segmented as with estrogens, progesterone, testosterone, and others. On the basis product type, the market is categorized as tablets and capsules, creams and gels, injectable, patches and implants, and others. Based on end user, the market is segmented as hospitals and clinics, academic and research, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the bioidentical hormones market based on various segments. It also provides market size and forecast estimates from year 2020 t o2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The bioidentical hormones market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting bioidentical hormones market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the bioidentical hormones market in these regions.
MARKET PLAYERS
The report covers key developments in the bioidentical hormones market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from bioidentical hormones market are anticipated to have lucrative growth opportunities in the future with the rising demand for bioidentical hormones in the global market. Below mentioned is the list of few companies engaged in the bioidentical hormones market.
The report also includes the profiles of key players in bioidentical hormones market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- NOVO NORDISK A/S
- BIOTE MEDICAL
- ADVANTAGE PHARMACEUTICALS, INC.
- BAYER AG
- NEUVA AESTHETICS
- MERCK KGAA
- BIOSTATION
- PFIZER INC.
- ALLERGAN
- NOVARTIS AG
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.